Abionic teams up with Genentech to develop rapid Asthma test

Abionic teams up with Genentech to develop rapid Asthma test Abionic has signed an agreement with Genentech to develop and provide rapid Point-of-Care tests for Asthma in the US. The pre-market process for the specific asthma panel will be managed by Abionic while Genentech will fund clinical and regulatory costs. In the U.S., 25 million

Go to Top